ANI Pharmaceuticals, Inc.

Q2 2021 13F Holders

Symbol
ANIP
CUSIP
00182C103
Type
Equity
Class
COM
Num filings
121
Total reported value, excl. options
$253 M
Manager Report Date Value ($000) Shares Option Type